Domainex is sponsoring the 9th RSC/SCI symposium on kinases, which will encompass plenary lectures on emergent topics and case studies of ongoing programmes, as well as successful past programmes. A range of topics including new screening approaches, brain penetrant kinase inhibitors, induced protein degradation, allosteric inhibitors and kinase inhibition for immuno-oncology will be covered, along with views and perspectives on the future of kinase inhibitor research.
Dr Mark Stewart (Team Leader, Medicinal Chemistry), Dr Rehan Aqil (Senior Scientist, Medicinal Chemistry) and Dr Cat Stace (Director of Business Development) will be attending.